Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

UNKNOWN × Brain Neoplasms × Vinorelbine × Clear all

Phase

Status

Sponsor Class

OTHER 2 UNKNOWN 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 3 Neoplasm Metastasis 1 Hormone Receptor Positive Advanced Breast Cancer 1 Carcinoma, Ductal, Breast 1 Brain Neoplasms 1

Interventions

pyrotinib 1 Vinorelbine 1 Radiotherapy, Intensity-Modulated 1 Pharmaceutical Preparations 1 Gefitinib 1 Erlotinib Hydrochloride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03933982 2019-05-29

Pyrotinib

ChineseAMS

Phase 2 Unknown

Brain Neoplasms, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡